The Clinical and Economic Potential of Cyclosporin Drug Interactions
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 15 (4) , 317-337
- https://doi.org/10.2165/00019053-199915040-00001
Abstract
The introduction of cyclosporin significantly improved solid organ transplantation outcomes. However, the costs associated with immunosuppressive therapy increased from approximately $US1000 to...Keywords
This publication has 97 references indexed in Scilit:
- Pharmacokinetic Drug Interactions with Antimicrobial AgentsClinical Pharmacokinetics, 1993
- The Effect of Cyclosporine on the Use of Hospital Resources for Kidney TransplantationNew England Journal of Medicine, 1990
- The Effect of Cyclosporine on the Use of Hospital Resources for Kidney TransplantationNew England Journal of Medicine, 1989
- Liver TransplantationNew England Journal of Medicine, 1989
- Comparison of Three Immunosuppressive Regimens in Cadaver Renal Transplantation: Long-Term Cyclosporine, Short-Term Cyclosporine Followed by Azathioprine and Prednisolone, and Azathioprine and Prednisolone without CyclosporineNew England Journal of Medicine, 1988
- Interaction of miconazole, ketoconazole and itraconazole with rat-liver microsornesXenobiotica, 1987
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1986
- Possible Interaction between Cyclosporine and ErythromycinNew England Journal of Medicine, 1986
- Effect of Erythromycin on Cyclosporine LevelsNew England Journal of Medicine, 1985
- Pharmacokinetic Interactions of the Macrolide AntibioticsClinical Pharmacokinetics, 1985